PAPERS
h-index 66 (and 36 since 2014)
Chen T, Mwenge L, Lakhi S, Chanda D , Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW; ACTA Trial Team. Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa. Clin Infect Dis. 2019 Mar 13. pii: ciy971. doi: 10.1093/cid/ciy971.
Cecilia Kanyama, Síle F Molloy, Adrienne K Chan, Duncan Lupiya, Chimwemwe Chawinga, Jack Adams, Philip Bright, David Lalloo, Angela Loyse, Robert S Heyderman, Olivier Lortholary, Shabbar Jaffar, Joep J van Oosterhout, Mina C Hosseinipour, Thomas S Harrison. One year mortality outcomes from the ACTA trial of cryptococcal meningitis treatment in Malawi. Clin Infect Dis. 2019 Jun 1. pii: ciz454. doi: 10.1093/cid/ciz454.
Kimaro GD, Guinness L, Shiri T, Kivuyo S, Chanda D, Bottomley C, Chen T, Kahwa A, Hawkins N, Mwaba P, Mfinanga SG, Harrison TS, Jaffar S, Niessen LW. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: a cost-effectiveness analysis. Clin Infect Dis. 2019 May 31. pii: ciz453. doi: 10.1093/cid/ciz453.
Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman R, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS. Addition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multi-country cost-effectiveness analysis. Clin Infect Dis 2019 Feb 28. pii: ciz163. doi: 10.1093/cid/ciz163.
Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, Branson K, Lawlor DA, Mwaiyeghele E, Nkhwazi L, Smeeth L, Pearce N, Munthali E, Mwagomba BM, Mwansambo C, Glynn JR, Jaffar S, Nyirenda M. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018; 6: 208-222.
S.F. Molloy, C. Kanyama, RS. Heyderman, A. Loyse, C. Kouanfack, D. Chanda, S. Mfinanga, E. Temfack, S. Lakhi, S. Lesikari, A.K Chan, N. Stone, N. Kalata, N. Karunaharan, K. Gaskell, M. Peirse, J. Ellis, C. Chawinga, S. Lontsi, J.-G. Ndong, P. Bright, D. Lupiya, T. Chen, J. Bradley, J. Adams, C. van der Horst, J.J. van Oosterhout, V. Sini, Y.N. Mapoure, P. Mwaba, T. Bicanic, D.G. Lalloo, D. Wang, M. C. Hosseinipour, O. Lortholary, S. Jaffar*, T. Harrison*, for the ACTA Trial Study Team. A randomised, controlled trial of the treatment of HIV-associated cryptococcal meningitis: oral fluconazole plus flucytosine or one week amphotericin B-based therapy vs two weeks amphotericin B-based therapy (The ACTA Trial). N Engl J Med. 2018;378:1004-1017 (* joint senior authors).
Mfinanga S, Chanda D, Lesikari S, Guinness L, Bottomley C, Chijoka C, Masasi A, Kimaro G, Ngowi B, Kahwa B, Mwaba P, Harrison TS, Egwaga S, Jaffar S . Cryptococcal meningitis screening and community-based early adherence support reduces all-cause mortality among HIV-infected people initiating antiretroviral therapy with advanced disease: a randomised-controlled trial in Tanzania and Zambia. The Lancet 2015; 385: 2173 -82 (fast-track).
Woodd SL, Grosskurth H, Levin J, Amuron B, Namara G, Birunghi J, Coutinho A, Jaffar S. Home-based versus clinic-based care for patients starting antiretroviral therapy with low CD4⁺ cell counts: findings from a cluster-randomized trial. AIDS. 2014; 28: 569-76.
Atun R, Jaffar S, Nishtar S, Knaul FM, Barreto ML, Nyirenda M, Banatvala N, Piot P. Improving responsiveness of health systems to non-communicable diseases. Lancet. 2013; 381: 690-7.
Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, Nabiryo G, Ndembi N, Kyomuhangi R, Opio A, Bunnell R, Tappero JW, Mermin J, Coutinho A, and Grosskurth H on behalf of the Jinja trial team. A cluster randomised trial of home-based and facility-based HIV-care: comparison of virologic failures, mortality and costs. The Lancet 2009; 374: 2080-9.